Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01089426 · ClinicalTrials.gov registry record · NA
Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01089426 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 90 participants.
The verdict
NCT01089426, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study examines the hypothesis that administering intravenous fish oil, in lieu of intravenous soybean oil, can ameliorate the progression of PN-associated cholestatic liver disease in pediatric patients with elevated direct bilirubin requiring PN for more than 30 days.
Interventions
- OTHER Historical Controls
- DRUG Omegaven™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-09 |
| Est. Completion | 2019-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01089426
The ClinicalTrials.gov registry entry for NCT01089426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Historical Controls is the first listed.
NCT01089426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01089426 about?
NCT01089426 is a clinical study titled "Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury". This study examines the hypothesis that administering intravenous fish oil, in lieu of intravenous soybean oil, can ameliorate the progression of PN-associated cholestatic liver disease in pediatric patients with elevated direct bilirubin requiring PN for more than 30 days.
What is the current status of trial NCT01089426?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2008-09. Estimated completion is 2019-04.
What interventions are being tested in trial NCT01089426?
The interventions under investigation include: Historical Controls (OTHER), Omegaven™ (DRUG).
Who is sponsoring clinical trial NCT01089426?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.